Skip to main content
Erschienen in: Journal of Gastroenterology 1/2012

01.01.2012 | Review

Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography–mass spectrometry

verfasst von: Masaru Yoshida, Naoya Hatano, Shin Nishiumi, Yasuhiro Irino, Yoshihiro Izumi, Tadaomi Takenawa, Takeshi Azuma

Erschienen in: Journal of Gastroenterology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Recently, metabolome analysis has been increasingly applied to biomarker detection and disease diagnosis in medical studies. Metabolome analysis is a strategy for studying the characteristics and interactions of low molecular weight metabolites under a specific set of conditions and is performed using mass spectrometry and nuclear magnetic resonance spectroscopy. There is a strong possibility that changes in metabolite levels reflect the functional status of a cell because alterations in their levels occur downstream of DNA, RNA, and protein. Therefore, the metabolite profile of a cell is more likely to represent the current status of a cell than DNA, RNA, or protein. Thus, owing to the rapid development of mass spectrometry analytical techniques metabolome analysis is becoming an important experimental method in life sciences including the medical field. Here, we describe metabolome analysis using liquid chromatography–mass spectrometry, gas chromatography–mass spectrometry (GC–MS), capillary electrophoresis–mass spectrometry, and matrix assisted laser desorption ionization–mass spectrometry. Then, the findings of studies about GC–MS-based metabolome analysis of gastroenterological diseases are summarized, and our research results are also introduced. Finally, we discuss the realization of disease diagnosis by metabolome analysis. The development of metabolome analysis using mass spectrometry will aid the discovery of novel biomarkers, hopefully leading to the early detection of various diseases.
Literatur
1.
Zurück zum Zitat Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998;16:373–8.PubMedCrossRef Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998;16:373–8.PubMedCrossRef
2.
Zurück zum Zitat Nambiar PR, Gupta RR, Misra V. An “Omics” based survey of human colon cancer. Mutat Res. 2010;693:3–18.PubMedCrossRef Nambiar PR, Gupta RR, Misra V. An “Omics” based survey of human colon cancer. Mutat Res. 2010;693:3–18.PubMedCrossRef
3.
Zurück zum Zitat Rochfort S. Metabolomics reviewed: a new “omics” platform technology for systems biology and implications for natural products research. J Nat Prod. 2005;68:1813–20.PubMedCrossRef Rochfort S. Metabolomics reviewed: a new “omics” platform technology for systems biology and implications for natural products research. J Nat Prod. 2005;68:1813–20.PubMedCrossRef
4.
Zurück zum Zitat Lewen J, Jing C, Peiyuan Y, Xin L, Guowang X. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics. 2008;4:183–9.CrossRef Lewen J, Jing C, Peiyuan Y, Xin L, Guowang X. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics. 2008;4:183–9.CrossRef
5.
Zurück zum Zitat Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab. 2008;7:135–47.PubMedCrossRef Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab. 2008;7:135–47.PubMedCrossRef
10.
Zurück zum Zitat Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910–4.PubMedCrossRef Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910–4.PubMedCrossRef
12.
Zurück zum Zitat Fukusaki E, Kobayashi A. Plant metabolomics: potential for practical operation. J Biosci Bioeng. 2005;100:347–54.PubMedCrossRef Fukusaki E, Kobayashi A. Plant metabolomics: potential for practical operation. J Biosci Bioeng. 2005;100:347–54.PubMedCrossRef
13.
Zurück zum Zitat Pongsuwan W, Fukusaki E, Bamba T, Yonetani T, Yamahara T, Kobayashi A. Prediction of Japanese green tea ranking by gas chromatography/mass spectrometry-based hydrophilic metabolite fingerprinting. J Agric Food Chem. 2007;55:231–6.PubMedCrossRef Pongsuwan W, Fukusaki E, Bamba T, Yonetani T, Yamahara T, Kobayashi A. Prediction of Japanese green tea ranking by gas chromatography/mass spectrometry-based hydrophilic metabolite fingerprinting. J Agric Food Chem. 2007;55:231–6.PubMedCrossRef
14.
Zurück zum Zitat Pongsuwan W, Bamba T, Yonetani T, Kobayashi A, Fukusaki E. Quality prediction of Japanese green tea using pyrolyzer coupled GC/MS based metabolic fingerprinting. J Agric Food Chem. 2008;56:744–50.PubMedCrossRef Pongsuwan W, Bamba T, Yonetani T, Kobayashi A, Fukusaki E. Quality prediction of Japanese green tea using pyrolyzer coupled GC/MS based metabolic fingerprinting. J Agric Food Chem. 2008;56:744–50.PubMedCrossRef
15.
Zurück zum Zitat Pongsuwan W, Bamba T, Harada K, Yonetani T, Kobayashi A, Fukusaki E. High-throughput technique for comprehensive analysis of Japanese green tea quality assessment using ultra-performance liquid chromatography with time-of-flight mass spectrometry (UPLC/TOF MS). J Agric Food Chem. 2008;56:10705–8.PubMedCrossRef Pongsuwan W, Bamba T, Harada K, Yonetani T, Kobayashi A, Fukusaki E. High-throughput technique for comprehensive analysis of Japanese green tea quality assessment using ultra-performance liquid chromatography with time-of-flight mass spectrometry (UPLC/TOF MS). J Agric Food Chem. 2008;56:10705–8.PubMedCrossRef
16.
Zurück zum Zitat Tianniam S, Tarachiwin L, Bamba T, Kobayashi A, Fukusaki E. Metabolic profiling of Angelica acutiloba roots utilizing gas chromatography-time-of-flight-mass spectrometry for quality assessment based on cultivation area and cultivar via multivariate pattern recognition. J Biosci Bioeng. 2008;105:655–9.PubMedCrossRef Tianniam S, Tarachiwin L, Bamba T, Kobayashi A, Fukusaki E. Metabolic profiling of Angelica acutiloba roots utilizing gas chromatography-time-of-flight-mass spectrometry for quality assessment based on cultivation area and cultivar via multivariate pattern recognition. J Biosci Bioeng. 2008;105:655–9.PubMedCrossRef
17.
Zurück zum Zitat Nishiumi S, Shinohara M, Ikeda A, Yoshie T, Hatano N, Kakuyama S, et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics. 2010;6:518–28.CrossRef Nishiumi S, Shinohara M, Ikeda A, Yoshie T, Hatano N, Kakuyama S, et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics. 2010;6:518–28.CrossRef
18.
Zurück zum Zitat Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. In press. Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. In press.
19.
Zurück zum Zitat Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T, et al. A GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis. 2011;17:2261–74. Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T, et al. A GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis. 2011;17:2261–74.
20.
Zurück zum Zitat Ooi M, Nishiumi S, Yoshie T, Shiomi Y, Kohashi M, Fukunaga K, et al. GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis. Imflamm Res. 2011;60:31–840. Ooi M, Nishiumi S, Yoshie T, Shiomi Y, Kohashi M, Fukunaga K, et al. GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis. Imflamm Res. 2011;60:31–840.
21.
Zurück zum Zitat Monton MR, Soga T. Metabolome analysis by capillary electrophoresis-mass spectrometry. J Chromatogr A. 2007;1168:237–46.PubMedCrossRef Monton MR, Soga T. Metabolome analysis by capillary electrophoresis-mass spectrometry. J Chromatogr A. 2007;1168:237–46.PubMedCrossRef
22.
Zurück zum Zitat Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem. 2006;281:16768–76.PubMedCrossRef Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem. 2006;281:16768–76.PubMedCrossRef
23.
Zurück zum Zitat Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69:4918–25.PubMedCrossRef Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69:4918–25.PubMedCrossRef
24.
Zurück zum Zitat Setou M, Kurabe N. Mass microscopy: high-resolution imaging mass spectrometry. J Electron Microsc (Tokyo). 2011;60:47–56.CrossRef Setou M, Kurabe N. Mass microscopy: high-resolution imaging mass spectrometry. J Electron Microsc (Tokyo). 2011;60:47–56.CrossRef
25.
Zurück zum Zitat Setou M, Shrivas K, Sroyraya M, Yang H, Sugiura Y, Moribe J, et al. Developments and applications of mass microscopy. Med Mol Morphol. 2010;43:1–5.PubMedCrossRef Setou M, Shrivas K, Sroyraya M, Yang H, Sugiura Y, Moribe J, et al. Developments and applications of mass microscopy. Med Mol Morphol. 2010;43:1–5.PubMedCrossRef
26.
Zurück zum Zitat Fernández-Bañares F, Cabré E, González-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn’s disease. Gut. 1994;35:55–9.CrossRef Fernández-Bañares F, Cabré E, González-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn’s disease. Gut. 1994;35:55–9.CrossRef
27.
Zurück zum Zitat Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060–83.PubMedCrossRef Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060–83.PubMedCrossRef
28.
Zurück zum Zitat Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, et al. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3111–7.PubMedCrossRef Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, et al. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3111–7.PubMedCrossRef
29.
Zurück zum Zitat Wu H, Xue R, Tang Z, Deng C, Liu T, Zeng H, et al. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem. 2010;396:1385–95.PubMedCrossRef Wu H, Xue R, Tang Z, Deng C, Liu T, Zeng H, et al. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem. 2010;396:1385–95.PubMedCrossRef
30.
Zurück zum Zitat Qui Y, Cai G, Su M, Chen T, Liu Y, Xu Y, et al. Urinary metabolomic study on colorectal cancer. J Proteome Res. 2010;9:1627–34.CrossRef Qui Y, Cai G, Su M, Chen T, Liu Y, Xu Y, et al. Urinary metabolomic study on colorectal cancer. J Proteome Res. 2010;9:1627–34.CrossRef
31.
Zurück zum Zitat Qui Y, Cai G, Su M, Chen T, Zeng X, Xu Y, et al. Serum metabolite profiling of human colorectal cancer using GC-TOF MS and UPLC-Q TOF MS. J Proteome Res. 2009;8:4844–50.CrossRef Qui Y, Cai G, Su M, Chen T, Zeng X, Xu Y, et al. Serum metabolite profiling of human colorectal cancer using GC-TOF MS and UPLC-Q TOF MS. J Proteome Res. 2009;8:4844–50.CrossRef
32.
Zurück zum Zitat Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, et al. Metabolite profiling of colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Cancer. 2008;7:72. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, et al. Metabolite profiling of colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Cancer. 2008;7:72.
33.
Zurück zum Zitat Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 2009;8:352–61.PubMedCrossRef Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 2009;8:352–61.PubMedCrossRef
34.
Zurück zum Zitat Ma Y, Liu W, Peng J, Huang L, Zhang P, Zhao X, et al. A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation. Mol Biol Rep. 2010;37:1403–11.PubMedCrossRef Ma Y, Liu W, Peng J, Huang L, Zhang P, Zhao X, et al. A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation. Mol Biol Rep. 2010;37:1403–11.PubMedCrossRef
35.
Zurück zum Zitat Kondo Y, Nishiumi S, Shinohara M, Hatano N, Ikeda A, Yoshie T, et al. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry. Biomark Med. 2011;5:451–60.PubMedCrossRef Kondo Y, Nishiumi S, Shinohara M, Hatano N, Ikeda A, Yoshie T, et al. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry. Biomark Med. 2011;5:451–60.PubMedCrossRef
36.
Zurück zum Zitat Xue R, Lin Z, Deng C, Dong L, Liu T, Wang J, et al. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2008;22:3061–8.PubMedCrossRef Xue R, Lin Z, Deng C, Dong L, Liu T, Wang J, et al. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2008;22:3061–8.PubMedCrossRef
37.
Zurück zum Zitat Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, et al. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta. 2009;648:98–104.PubMedCrossRef Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, et al. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta. 2009;648:98–104.PubMedCrossRef
38.
Zurück zum Zitat Urayama S, Zou W, Brooks K, Tolstikov V. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom. 2010;24:613–20.PubMedCrossRef Urayama S, Zou W, Brooks K, Tolstikov V. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom. 2010;24:613–20.PubMedCrossRef
39.
Zurück zum Zitat Xue R, Dong L, Wu H, Liu T, Wang J, Shen X. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med. 2009;47:305–10.PubMedCrossRef Xue R, Dong L, Wu H, Liu T, Wang J, Shen X. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med. 2009;47:305–10.PubMedCrossRef
40.
Zurück zum Zitat Hu JD, Tang HQ, Zhang Q, Fan J, Hong J, Gu JZ, et al. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. World J Gastroenterol. 2011;17:727–34.PubMedCrossRef Hu JD, Tang HQ, Zhang Q, Fan J, Hong J, Gu JZ, et al. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. World J Gastroenterol. 2011;17:727–34.PubMedCrossRef
41.
Zurück zum Zitat Li ZF, Wang J, Huang C, Zhang S, Yang J, Jiang A, et al. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis. Rapid Commun Mass Spectrom. 2010;24:2765–75.PubMedCrossRef Li ZF, Wang J, Huang C, Zhang S, Yang J, Jiang A, et al. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis. Rapid Commun Mass Spectrom. 2010;24:2765–75.PubMedCrossRef
42.
Zurück zum Zitat Lin HM, Edmunds SJ, Helsby NA, Ferguson LR, Rowan DD. Nontargeted urinary metabolite profiling of a mouse model of Crohn’s disease. J Proteome Res. 2009;8:2045–57.PubMedCrossRef Lin HM, Edmunds SJ, Helsby NA, Ferguson LR, Rowan DD. Nontargeted urinary metabolite profiling of a mouse model of Crohn’s disease. J Proteome Res. 2009;8:2045–57.PubMedCrossRef
43.
Zurück zum Zitat Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, et al. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn’s disease. J Proteome Res. 2010;9:1965–75.PubMedCrossRef Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, et al. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn’s disease. J Proteome Res. 2010;9:1965–75.PubMedCrossRef
Metadaten
Titel
Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography–mass spectrometry
verfasst von
Masaru Yoshida
Naoya Hatano
Shin Nishiumi
Yasuhiro Irino
Yoshihiro Izumi
Tadaomi Takenawa
Takeshi Azuma
Publikationsdatum
01.01.2012
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 1/2012
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-011-0493-8

Weitere Artikel der Ausgabe 1/2012

Journal of Gastroenterology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.